...
nmol/àL) and the preceding dilution 1 : 10 which
shows an averaged relaxation time slightly decreased
from 11 26.9 to 11 01 .1 ms. This finding corresponds to
the quantification of T1 relaxation ... below as a
basis for determining MRI tomographical signals in
comparison to the commonly used MRI contrast agent
(CA) Gd-DTPA.
MRI-Measurements in MDA-MB-2 31 breast ade-
nocarcinoma cells ... Letters. 19 94; 229: 11 5- 21.
50. Mikawa M, Kato H, Okumura M, et al. Paramagnetic
water-soluble metallofullerenes having the highest relaxivity
for MRI contrast agents. Bioconjug Chem. 20 01; 12 : 510 - 4....
... [ Team LiB ]
Recipe 10 . 6 CreatingaNew Access Database
Problem
You need to create anew Microsoft Access database.
Solution
Use ActiveX Database Objects Extensions (ADOX) from ... the database.
CreateAccessDatabase( )
This method uses ADOX through COM interop to create the new Access database
having the specified filename.
The C# code is shown in Example 10 - 6
.
Example ... @"Provider=Microsoft.Jet.OLEDB.4.0;Data Source=" +
fileName + ";";
// Use ADOX to create the Access database.
ADOX.Catalog cat = new ADOX.Catalog( );
try
{
cat.Create(connectString);
}
finally...
... a DDL CREATE DATABASE statement to create anew database
on a SQL Server.
You can programmatically drop the database by using the DROP DATABASE statement
in a similar way. To drop the database ...
[ Team LiB ]
Recipe 10 . 7 CreatingaNew SQL Server Database
Problem
You need to create anew database in your SQL Server.
Solution
Use the CREATE DATABASE statement.
The sample code ...
StringBuilder sb = new StringBuilder( );
// SQL DDL command text to create database.
String sqlText = "CREATE DATABASE MyDatabase ON PRIMARY " +
"(NAME = MyDatabase_Data, " +...
... 60,000
Deaths: 30,000
10
AUSTRALIA /NEW ZEALAND
Total Infected: 15 ,000
Newly Infected: 500
Deaths: 12 0
PREDOMINANT
HIV CLADES
CLADE A
CLADE B
CLADE C
CLADE D
CLADE E
OTHER
NO INFORMATION
WORLD
Total Infected: ... dresses.”
14 SCIENTIFIC AMERICAN JUNE 2002
Tr ansistor Sales
■
Meat Business
■
Amazon Trade
DDT DELIVERY in the Italian
antimalaria campaign, 19 52
50, 10 0 & 15 0 Years Ago
FROM SCIENTIFIC AMERICAN
COPYRIGHT ... for
Malaria on page 10 2 of this issue traces the historical
reason
—the lack of a viable market for antimalarial
pharmaceuticals. This situation is at least as pervasive
today: drug companies are...
... coding assistance, we thank Johanna Bötscher, Martina Castro, Kristina
Hauser, Benjamin Hofmann, Theresa Kuhn, Salome Lang, Justin Leinaweaver, Julie Mandoyan, Martiño Rubal
Maseda, Claudia ... apparent.
Europe Asia Africa America Oceania Cross
Region
Percentage
0 5 10 15 20 25 30
Positive approach
Negative approach
Europe Asia Africa America Oceania Cross
Region
Percentage
0 5 10 15 20 25 ... Describing aNew Dataset for aNew Research Agenda,”
Economie Internationale 10 9 :53-82.
Ethier Wilfred 19 98. “The New Regionalism,” The Economic Journal 10 8 (3) :11 49- 61.
Fernandez Raquel and Jonathan...
... relating
to low potency and cost. Peptide-based drug candidates
are limited by insufficient efficacy and unfavorable phar-
macokinetics. MAbs have increasingly gained favor in
large part because ... Amerimmune Pharmaceuticals, Inc. HIV/AIDS I/II
Tipranavir TIPRANAVIR HIV/AIDS III
HXB AAI International, AnaaiPharma Company Herpes Simplex Virus type 2 Preclinical
MEDI-4 91 MedImmune Human B19 parvovirus ... Anew
paradigm in medicine for infectious diseases
Hervé Le Calvez*
1
, Mang Yu
2
and Fang Fang
2
Address:
1
Abgent, Inc. 6 310 Nancy Ridge Drive, Suite 10 6 , San Diego, CA 9 212 1 USA and
2
NexBio,...
...
A new pathway in need assessment Journal of Occupational Medicine and
Toxicology 2 010 , 5:20
Received: 28 January 2 010 Accepted: 12 July 2 010
Published: 12 July 2 010
This article is available ... preparation for the current analysis.
RP participated at data acquisition and data preparation for the current analy-
sis.
TU participated in the design of the study and at the data preparation.
JB ... regression analysis at t -1 was used as
additional covariate.
The last analysis was focused on the association
between health factors and participation. This result has
to be taken into account for...
... relating
to low potency and cost. Peptide-based drug candidates
are limited by insufficient efficacy and unfavorable phar-
macokinetics. MAbs have increasingly gained favor in
large part because ... Amerimmune Pharmaceuticals, Inc. HIV/AIDS I/II
Tipranavir TIPRANAVIR HIV/AIDS III
HXB AAI International, AnaaiPharma Company Herpes Simplex Virus type 2 Preclinical
MEDI-4 91 MedImmune Human B19 parvovirus ... DG,
Sundquist WI: Tsg1 01 and the vacuolar protein sorting path-
way are essential for HIV -1 budding. Cell 20 01, 10 7 :55-65.
50. Martinez MA, Gutierrez A, Armand-Ugon M, Blanco J, Parera M,
Gomez J, Clotet...
...
Ventilation Air
Return Air
Natural Gas
Supply Air
Figure 2 -15 Example diagram of a packaged DEVap A/ C
Figure 2 16 illustrates how a DEVap RTU would be installed on a commercial building
application. ... preheating the ambient air
using an air-to-air heat exchanger (AAHX). The air comes into heat and mass exchange with the
hot desiccant (in this example at 19 0°F) and carries the desorbed water ... react to it accordingly to maintain
temperature and humidity. To match the space load, an A/ C system must provide air along a
constant SHR originating from the space condition (76°F and varying...
... article as: Cocchi et al., Human depression: anew approach in
quantitative psychiatry Annals of General Psychiatry 2 010 , 9:25
Cocchi et al. Annals of General Psychiatry 2 010 , 9:25
http://www.annals-general-psychiatry.com/content/9 /1/ 25
Open ... of diagnosis, suicide, and treatment at the
time of death. J Neurochem 19 99, 73 :11 21- 112 6.
Received: 18 January 2 010 Accepted: 3 June 2 010
Published: 3 June 2 010
This article is available from: ... design and concept of
the study. MC and LT were particularly involved in data collection and data
analysis. All authors were involved in the interpretation of the data. All the
authors have been involved...
... diseases by damaging tissue and releasing
pro -in ammatory agents. Activated eosinophils, neutro-
phils, macrophages and lymphocytes increase in number at
sites of in ammation and each are capable of ... probe
length (bp)
L3 713 –733 5
0
-TGCTCAGCTTCACGCCCAGAC-3
0
732
14 36 14 45 3
0
-TGCACGGAGAGGCTGAGAGA-5
0
S1 545–563 5
0
-CTCAGAAGCCTGATGTCTA-3
0
16 6
693– 710 3
0
-GAGAAGTGGGAGGTCGTT-5
0
S2 14 58 14 76 5
0
2CTGCTGGGCCCCTCCTGC-3
0
237
16 76 16 95 ... cell
adhesion as sialidase often interrupts binding. In particular,
an arginine residue within the first Ig domain is a key amino-
acid residue for binding to SIA [2]. Comparison of the
N-terminal...